Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy - Ogawa, Susumu; Mori, Takefumi; Nako, Kazuhiro; Ito, Sadayoshi (Hypertension research, 2008)
Keywords: Adult; Aged; albuminuria; Angiotensin II Type 1 Receptor Blockers - administration & dosage; Angiotensin-Converting Enzyme Inhibitors - administration & dosage; azelnidipine; Azetidinecarboxylic Acid - administration & dosage; Azetidinecarboxylic Acid - analogs & derivatives; C-Reactive Protein - analysis; Calcium Channel Blockers - administration & dosage; Creatinine - urine; Deoxyguanosine - analogs & derivatives; Deoxyguanosine - urine; Diabetic Nephropathies - drug therapy; Diabetic Nephropathies - metabolism; diabetic nephropathy; Dihydropyridines - administration & dosage; Dinoprost - analogs & derivatives; Dinoprost - urine; Drug Therapy, Combination; Female; Geriatrics/Gerontology; Health Promotion and Disease Prevention; Humans; inflammation; Interleukin-6 - blood; Internal Medicine; Male; Medicine; Medicine & Public Health; Middle Aged; Obstetrics/Perinatology/Midwifery; original-article; Oxidative Stress; Public Health; albuminuria; azelnidipine; inflammation; diabetic nephropathy; oxidative stress